This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Frontiers in Cardiovascular Medicine
APRIL 23, 2025
IntroductionThe definition of acute kidney dysfunction in patients with acute decompensated heart failure (ADHF) remains unclear. KDIGO exhibited higher discriminatory power compared with WRF-Scr and WRF-eGFR for in-hospital mortality[area under the curve (AUC):73.6% vs. 71.2%].
HCPLive
MAY 20, 2024
A numerically slower decline in eGFR was reported in the finerenone cohort after hospitalization for heart failure when compared with placebo.
116 
The British Journal of Cardiology
JANUARY 14, 2025
Heart failure (HF) is a significant problem in the UK with variation in services across the country. Seventy-nine responses describing hospital-based HF services from all devolved countries were received. The clinical lead in 82% of hospitals was a cardiologist with specialist interest in HF. and 75%, respectively.
HCPLive
FEBRUARY 8, 2024
Deepak Bhatt, MD, MPH, discusses the need to improve in-hospital initiation and uptitration of guideline-directed medical therapy in heart failure.
130 
Becker's Hospital Review - Cardiology
JANUARY 27, 2025
In partnership with Abbott, the American Heart Association has launched a $3 million initiative to address knowledge gaps found within heart failure treatment education that may be contributing to cardiovascular care disparities.
115 
Becker's Hospital Review - Cardiology
AUGUST 14, 2024
Luke's Regional Medical Center has the lowest readmission rate for heart failure patients, CMS found. Boise, Idaho-based St.
116 
Medical Xpress - Cardiology
JANUARY 31, 2025
People hospitalized for infectionsalmost any infectionsare at substantially increased risk years later for heart failure, according to collaborative research by the University of Minnesota and Mayo Clinic.
124 
European Journal of Heart Failure
JANUARY 20, 2025
Remote patient monitoring in heart failure (HF). Abstract Aims Methods of non-invasive remote patient monitoring (RPM) for heart failure (HF) remain diverse. 95% confidence interval [CI] 0.690.95; I 2 =0.39) and reduced first HF hospitalization risk (pooled OR 0.78, 95% CI: 0.700.87; I 2 =0.21) compared to usual care.
DAIC
JULY 31, 2024
mtaschetta-millane Wed, 07/31/2024 - 06:00 July 31, 2024 — A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & Vascular Institute, demonstrates the effectiveness of a newly developed scoring system in identifying patients with Heart Failure with Preserved Ejection Fraction (HFpEF).
111 
DAIC
APRIL 25, 2025
Researchers presented these findings as late-breaking clinical science during Heart Rhythm 2025. Heart failure impacts more than 64 million people worldwide. Global burden of heart failure: a comprehensive and updated review of epidemiology. For more information, visit www.HRSonline.org. Cardiovasc Res.
DAIC
MARCH 6, 2024
a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc.
128 
Frontiers in Cardiovascular Medicine
MARCH 5, 2025
BackgroundHeart failure (HF), a global health challenge, is a leading cause of mortality in hospitalized patients. The association between ACC and clinical outcomes in HF patients was analyzed using Cox proportional hazards regression and restricted cubic spline models.ResultsA total of 4,737 heart failure patients were included.
DAIC
MAY 2, 2024
(‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: Heart Failure. Heart failure (HF) is a leading cause of hospitalization in the United States.
105 
DAIC
FEBRUARY 12, 2024
A team at Allina Health’s Abbott Northwestern Hospital has successfully completed the first Barostim Baroreflex Activation Therapy implant in the state of Minnesota, according to an announcement from CVRx, Inc. and Allina Health. and Allina Health. and Allina Health. The Minneapolis, MN-based company received U.S.
104 
Heart BMJ
FEBRUARY 12, 2025
In adults with congenital heart disease (ACHD patients), atrial arrhythmias (AA) and heart failure (HF) are common. Of these, AA is one of the leading causes for hospital admissions in ACHD care.
Medical Xpress - Cardiology
JULY 29, 2024
A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & Vascular Institute demonstrates the effectiveness of a newly developed scoring system in identifying patients with Heart Failure with Preserved Ejection Fraction (HFpEF).
JAMA Cardiology
DECEMBER 26, 2023
This secondary analysis of the Safety, Tolerability, and Efficacy of Rapid Optimization, Helped by N-Terminal Pro–Brain Natriuretic Peptide Testing of Heart Failure Therapies (STRONG-HF) randomized clinical trial investigates what variables are associated with success in uptitration of guideline-directed medical therapy after hospital discharge for (..)
105 
Open Heart
FEBRUARY 27, 2025
Background Iron deficiency (ID) is a highly prevalent comorbidity in patients with chronic and acute heart failure and is associated with worse clinical outcomes. We aimed to evaluate the prevalence and clinical characteristics of ID and its association with in-hospital congestion and postdischarge outcomes.
HCPLive
APRIL 7, 2024
Veraprapas Kittipibul, MD, discusses a study examining costs associated with heart failure hospitalization among patients with HFrEF or HFpEF from within the GWTG-HF registry.
Becker's Hospital Review - Cardiology
OCTOBER 8, 2024
based UMass Memorial Health-Harrington Hospital reduced the all-cause 30-day readmission for heart failure patients by 50% as part of a remote patient monitoring program with digital health company Brook Health. Southbridge, Mass.-based
Becker's Hospital Review - Cardiology
NOVEMBER 25, 2024
Of those, 97 hospitals were recognized for delivering superior clinical outcomes in cardiac care for heart bypass surgery, coronary interventional procedures, heart attack treatment, heart failure treatment and heart valve surgery. Healthgrades published its 2025 Specialty Excellence Awards recipients Oct.
105 
Cardiology Update
APRIL 25, 2024
RELIEVE-HF investigators evaluated the efficacy and safety of the V-wave interatrial shunt system in patients with heart failure. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. Atlanta, GA.
Frontiers in Cardiovascular Medicine
JANUARY 23, 2025
Background Early prediction of heart failure (HF) after acute myocardial infarction (AMI) is essential for personalized treatment. The primary endpoint was the occurrence of HF within 3 years after operation.
DAIC
SEPTEMBER 19, 2024
recently announced that Digitiva, a non-invasive digital health solution for heart failure management, has been listed with the U.S. a smartphone app designed for heart failure patients and built on the Welldoc, Inc. tim.hodson Thu, 09/19/2024 - 09:42 Sept. 18, 2024 – Astellas Pharma Inc.
105 
DAIC
FEBRUARY 26, 2024
milla1cf Mon, 02/26/2024 - 12:40 February 26, 2024 — More than 6 million Americans live with heart failure , and about half have an enlarged left ventricle, which causes stress on the heart and less blood pumped with each heartbeat. Patients may experience trouble breathing and fatigue, and at times require hospitalization.
119 
European Journal of Heart Failure
FEBRUARY 16, 2025
Baseline characteristics for the vericiguat global study in participants with chronic heart failure (VICTOR) trial. of participants had no prior hospitalization for heart failure. Conclusion The VICTOR trial enrolled the most optimally treated population in a phase III heart failure trial.
European Journal of Heart Failure
MARCH 10, 2025
Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis. Clonal haematopoiesis and heart failure: a meta-analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heart failure.
DAIC
FEBRUARY 6, 2024
Matthew Segar co-authored a study in JACC Heart Failure led by his research and residency mentor, University of Texas Southwestern Medical Center's Dr. Ambarish Pandey , that utilized a machine learning-based-approach to identify, understand, and predict diuretic responsiveness in patients with acute decompensated heart failure (ADHF).
111 
Becker's Hospital Review - Cardiology
APRIL 3, 2024
The FDA has approved an artificial intelligence algorithm for Eko Health's digital stethoscope that can detect low ejection fraction, a key indicator of heart failure.
115 115 
Becker's Hospital Review - Cardiology
SEPTEMBER 16, 2024
Discover the top 10 hospitals with the highest excess readmission rates for heart failure patients, according to CMS' hospital readmissions reduction program
HCPLive
JANUARY 25, 2024
Lower levels of selenoprotein P were associated with reduced hemoglobin, greater transferrin receptor 1, and an increased prevalence of anemia in a cohort of hospitalized heart failure patients.
European Journal of Heart Failure
MARCH 12, 2025
Patients with heart failure (HF) experience much worse QoL and effort intolerance than both the general population and people with other chronic conditions, since they present a range of physical and psychological symptoms, including shortness of breath, chest discomfort, fatigue, fluid congestion, trouble with sleeping, and depression.
DAIC
JUNE 21, 2024
announced that the peer-reviewed Journal of the American College of Cardiology: Heart Failure has published a research paper concluding that INPEFA (sotagliflozin) is cost-effective for people with diabetes and recent worsening heart failure using commonly accepted willingness-to-pay thresholds. “Our healthcare system.
105 
Frontiers in Cardiovascular Medicine
MARCH 7, 2024
However, information on its efficacy and safety in patients with heart failure remains limited. Case presentation A 43-year-old man with a body mass index of 41 kg/m 2 was admitted to our hospital for acute heart failure due to dilated cardiomyopathy. No adverse events were observed during B-SES.
124 
Circulation
APRIL 13, 2025
Heart failure is a growing health-care concern affecting tens of millions of individuals globally. Although traditional therapeutic strategies have focused on reducing the risk for hospitalization and mortality, the importance of patient-reported outcomes (PROs) in patients with heart failure is increasingly being recognized.
Becker's Hospital Review - Cardiology
JUNE 18, 2024
A Seattle-based UW Medicine heart failure program is keeping patients out of the hospital and providing indefinite care for vulnerable heart failure patients.
Becker's Hospital Review - Cardiology
OCTOBER 2, 2024
One in 4 Americans (24%) will develop heart failure in their lifetime, according to a new report published Sept. 24 in the Journal of Cardiac Failure.
110 110 
DAIC
FEBRUARY 21, 2024
Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices.
105 
Medical Xpress - Cardiology
JANUARY 1, 2024
For adults with congenital heart disease (ACHD), those with heart failure (HF) hospitalizations have an increased risk for mortality and morbidity, according to a study published in the Dec. 5 issue of the Journal of the American Heart Association.
Med Page Today
APRIL 1, 2025
(MedPage Today) -- CHICAGO -- Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heart failure (HF) hospitalization for this technology.
52 
Cardiovascular Diabetology
SEPTEMBER 15, 2024
Background Heart failure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovascular disease. In addition, we investigated the beneficial effects of fenofibrate on HF hospitalization. During the 4.22-year
98 
Becker's Hospital Review - Cardiology
JANUARY 3, 2024
Dallas-based UT Southwestern Medical Center researchers found a two-step screening protocol combining clinical risk assessment with biomarker testing that can identify which patients with Type 2 diabetes need medication to prevent heart failure.
110 
DAIC
MAY 28, 2024
milla1cf Tue, 05/28/2024 - 07:00 May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024 , a scientific congress of the European Society of Cardiology (ESC).
Frontiers in Cardiovascular Medicine
JANUARY 22, 2025
IntroductionThe objective of this study was to examine the impact of ventricular assist device support as a bridge to heart transplantation in children with end-stage heart failure. The mean length of hospital stay (days) was 214209 in group 1 and 12891 days in group 2.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content